{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:20:29Z","timestamp":1781119229915,"version":"3.54.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The detection of neural autoantibodies in patients with cognitive decline is an increasingly frequent phenomenon in memory clinics, and demanding as it does a specific diagnostic approach and therapeutic management, it deserves greater attention. It is this review\u2019s aim to present the latest nosology of neural autoantibody-associated dementia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A specific literature research via PubMed was conducted to describe the nosology of neural autoantibody-associated dementia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>An autoimmune dementia comprises with an early onset, atypical clinical presentation and rapid progression in conjunction with neural antibodies, signs of inflammation in the cerebrospinal fluid, and a non-neurodegenerative pattern in neuroimaging. An autoimmune dementia is probably present if the patient responds to immunotherapy. Atypical dementia involving neural autoantibodies with mostly N-methyl-D-aspartate receptor antibodies might not fulfill all the autoimmune-dementia criteria, thus it may constitute an independent disease entity. Finally, a neurodegenerative dementia such as the frontotemporal type also coincides with neural autoantibodies such as the subunit ionotropic glutamate receptors 3 of amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibodies, dementia with Lewy bodies with myelin oligodendrocytic protein, myelin basic protein antibodies, or Creutzfeldt-Jakob disease with Zic4 or voltage gated potassium channel antibodies. These dementia entities may well overlap in their clinical features and biomarkers, i.e., their neural autoantibodies or neuroimaging patterns.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There are three main forms of neural autoantibody-associated dementia we can distinguish that might also share certain features in their clinical and laboratory presentation. More research is urgently necessary to improve the diagnosis and therapy of these patients, as the progression of their dementia might thus be improved or even reversed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2021.711195","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T11:34:26Z","timestamp":1627472066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Current Nosology of Neural Autoantibody-Associated Dementia"],"prefix":"10.3389","volume":"13","author":[{"given":"Niels","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"B1","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5<sup>\u00ae<\/sup>), Fifth Edition."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421998906","article-title":"Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression.","volume":"14","author":"Banks","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06117-y","article-title":"Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.","volume":"7","author":"Borroni","year":"2017","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000577","article-title":"Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy.","volume":"6","author":"Brunetti","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies.","volume":"2020","author":"Budhram","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ene.12942","article-title":"Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.","volume":"23","author":"Constantinescu","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu\u2013associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients.","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011937","article-title":"Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.","volume":"2021","author":"Day","year":"2021","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000701","article-title":"Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.","volume":"7","author":"D\u00e9chelotte","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.0000000000003586","article-title":"Characteristics in limbic encephalitis with antiadenylate kinase 5 autoantibodies.","volume":"88","author":"Do","year":"2017","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acn3.120","article-title":"High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types.","volume":"1","author":"Doss","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00163","article-title":"CD8(+) T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis.","volume":"6","author":"Ehling","year":"2015","journal-title":"Front. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response.","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09825-0","article-title":"Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis.","volume":"2020","author":"Gibson","year":"2020","journal-title":"J. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/JAD-190962","article-title":"Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-\u03b21-42 and Key Cell Surface Proteins During Alzheimer\u2019s Disease Pathogenesis.","volume":"74","author":"Goldwaser","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants.","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jamaneurol.2013.4857","article-title":"Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.","volume":"71","author":"Grau-Rivera","year":"2014","journal-title":"JAMA Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1212\/wnl.0000000000002775","article-title":"Human neurexin-3\u03b1 antibodies associate with encephalitis and alter synapse development.","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.641101","article-title":"Locus Coeruleus Malfunction Is Linked to Psychopathology in Prodromal Dementia With Lewy Bodies.","volume":"13","author":"Hansen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.626121","article-title":"Case report: anti-flotilin \u00bd autoantibody-associated atypical dementia.","volume":"2021","author":"Hansen","year":"","journal-title":"Front. Psych."},{"key":"B22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yebeh.2017.10.033","article-title":"Pre- and long-term postoperative courses of hippocampus-associated memory impairment in epilepsy patients with antibody-associated limbic encephalitis and selective amygdalohippocampectomy.","volume":"79","author":"Hansen","year":"2018","journal-title":"Epilepsy Behav."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00576","article-title":"Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis.","volume":"11","author":"Hansen","year":"","journal-title":"Front. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00702-021-02316-0","article-title":"Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort.","volume":"128","author":"Hansen","year":"","journal-title":"J. Neural. Transm."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106682","article-title":"Low CSF CD4\/CD8+ T-cell proportions are associated with blood-CSF barrier dysfunction in limbic encephalitis.","volume":"102","author":"Hansen","year":"","journal-title":"Epi. Behav."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/wnl.0000000000003796","article-title":"DPPX antibody-associated encephalitis: main syndrome and antibody effects.","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1212\/WNL.0000000000005329","article-title":"Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.","volume":"90","author":"Hara","year":"2018","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00415-020-10158-1","article-title":"Specific B- and T-cell populations are associated with cognition in patients with epilepsy and antibody positive and negative suspected limbic encephalitis.","volume":"268","author":"Helmstaedter","year":"2021","journal-title":"J. Neurol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients.","volume":"8","author":"Herken","year":"2017","journal-title":"Front. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/wnl.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/wnl.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients.","volume":"84","author":"Hoftberger","year":"2015","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies.","volume":"80","author":"Honnorat","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201622","article-title":"Presence of voltage-gated potassium channel complex antibody in a case of genetic prio disease.","volume":"2014","author":"Jammoul","year":"2014","journal-title":"BJM Case Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration.","volume":"88","author":"Landa","year":"2020","journal-title":"Ann. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.","volume":"88","author":"Lang","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000386","article-title":"Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity.","volume":"4","author":"Lang","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21140.1","article-title":"Putative autoantibodies in the cerebrospinal fluid of Alzheimer\u2019s disease patients.","volume":"11","author":"Lim","year":"2019","journal-title":"F1000Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/jnnp-2018-320168","article-title":"Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis.","volume":"90","author":"Loane","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000178","article-title":"Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jacob disease.","volume":"12","author":"Maat","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/JAD-2011-110221","article-title":"Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.","volume":"26","author":"Maetzler","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10072-020-04828-1","article-title":"Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice.","volume":"42","author":"Marchionatti","year":"2021","journal-title":"Neurol. Sci."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000666","article-title":"Clinical significance of Kelch-like protein 11 antibodies.","volume":"7","author":"Maudes","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/archneur.64.10.1528","article-title":"Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome.","volume":"64","author":"McKeon","year":"2007","journal-title":"Arch. Neurol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41836","article-title":"Human hippocampal CA3 damage disrupts both recent and remote episodic memories.","volume":"24","author":"Miller","year":"2020","journal-title":"Elife"},{"key":"B48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nrl.2016.05.010","article-title":"Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes.","volume":"33","author":"Ortega Suero","year":"2018","journal-title":"Neurologia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2019.10.015","article-title":"Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.","volume":"86","author":"Palese","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments.","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann. Neurol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01482","article-title":"The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested.","volume":"11","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clineuro.2018.02.043","article-title":"Atypical presentation of probable Creutzfeldt-Jacob disease associated with anti-Zic4 antibody: literature review of neuronal antibodies in Creutzfeldt-Jacob disease.","volume":"168","author":"Salazar","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years.","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40976-x","article-title":"High-throughput epitope profiling of antibodies in the plasma of Alzheimer\u2019s disease patients using random peptide microarrays.","volume":"9","author":"Sim","year":"2019","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/wnl.0000000000003713","article-title":"Investigations in GABAA receptor antibody associated encephalitis.","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"B56","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","article-title":"Encephalitiswith mGluR5 antibodies: symptoms and antibody effects.","volume":"90","author":"Spatola","year":"2018","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/ene.13721","article-title":"Antiglycine receptor antibody related disease: a case series and literature review.","volume":"25","author":"Swayne","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11010089","article-title":"KCNA2 Autoimmunity in Progressive Cognitive Impairment: Case Series and Literature.","volume":"11","author":"Tim\u00e4us","year":"2021","journal-title":"Rev. Brain"},{"key":"B59","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/wnl.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibodyassociated disease.","volume":"87","author":"Van Sonderen","year":"","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/WNL.0000000000002637","article-title":"The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.","volume":"86","author":"Van Sonderen","year":"","journal-title":"Neurology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias.","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"B62","first-page":"22","article-title":"Paraneoplastic limbic encephalitis in an elderly patient with small cell lung carcinoma.","volume":"79","author":"White","year":"2010","journal-title":"Ulster Med. J."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000670","article-title":"Encephalitis with radial perivascular emphasis: Not necessarily associated with GFAP antibodies.","volume":"7","author":"Wickel","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B64","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/CM9.0000000000001427","article-title":"Cerebral amyloid angiopathy-related inflammation: current status and future implications.","volume":"134","author":"Wu","year":"2021","journal-title":"Chin. Med. J."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X17750928","article-title":"Auto-antibodies against P\/Q- and N-type voltage-dependent calcium channels mimicking frontotemporal dementia.","volume":"6","author":"Younes","year":"2018","journal-title":"Open Med. Case Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10072-020-04482-7","article-title":"Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-D-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study.","volume":"42","author":"Zeng","year":"2021","journal-title":"Neurol Sci."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.577114","article-title":"Anti-dipeptidyl-peptidase-like protein 6 encephalitis, a rare cause of reversible rapid progressive dementia and insomnia.","volume":"339","author":"Zhou","year":"2020","journal-title":"J. Neuroimmunol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.711195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T11:34:30Z","timestamp":1627472070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.711195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":67,"alternative-id":["10.3389\/fnagi.2021.711195"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.711195","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"article-number":"711195"}}